Jerome D. Jabbour
2015
In 2015, Jerome D. Jabbour earned a total compensation of $443K as President at Matinas BioPharma Holdings, a 23% decrease compared to previous year.
Compensation breakdown
| Bonus | $90,750 |
|---|---|
| Option Awards | $59,289 |
| Salary | $293,000 |
| Total | $443,039 |
Jabbour received $293K in salary, accounting for 66% of the total pay in 2015.
Jabbour also received $90.8K in bonus and $59.3K in option awards.
Rankings
In 2015, Jerome D. Jabbour's compensation ranked 11,260th out of 13,638 executives tracked by ExecPay. In other words, Jabbour earned more than 17.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,260 out of 13,638 | 17th |
Division Manufacturing | 4,306 out of 5,187 | 17th |
Major group Chemicals And Allied Products | 1,588 out of 1,857 | 15th |
Industry group Drugs | 1,309 out of 1,531 | 15th |
Industry Pharmaceutical Preparations | 1,013 out of 1,179 | 14th |
Source: SEC filing on September 14, 2017.
Jabbour's colleagues
We found three more compensation records of executives who worked with Jerome D. Jabbour at Matinas BioPharma Holdings in 2015.
News
Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
September 19, 2023
Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
September 22, 2022
Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
October 1, 2020
Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
September 24, 2019